Sen. Durbin Questions Francis Collins on March-In Rights, April 7, 2016 at Senate Hearing

KEIWashDC
121
195 views

Transcript

The interactive transcript could not be loaded.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Sep 25, 2016

On April 7, 2016, Senator Dick Durbin (D-IL) questioned NIH Director Francis Collins on the use of Bayh-Dole Act march-in rights with regard to NIH grant-funded high priced drugs. Collins mentioned the Xtandi march-in request, and expressed concerns over the negative consequences of using the public's rights in NIH-funded patents to curb high drug prices. Durbin disagreed.

Hearing on FY2017 National Institutes of Health Budget Request, before the Senate Appropriations Committee Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

Date: Thursday, April 7, 2016 Time: 10:00 AM Location: Dirksen Senate Office Building 138

More on the Xtandi case at http://keionline.org/xtandi

Full hearing is available here: http://www.appropriations.senate.gov/...

When autoplay is enabled, a suggested video will automatically play next.

Up next

to add this to Watch Later

Add to